PATENT CLAIM ANALYSIS

Application Number: 15974817
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Claim (Index 42):
A method of treating an inflammatory condition involving a phagocytic immune response, the method comprising administering to a patient in need thereof an effective amount of a formulation, said formulation comprising a plurality of liposomes, said liposomes having a lipid ingredient and encapsulating a therapeutic agent, having a mass ratio of said therapeutic agent to lipid of about 1:5 to 1:8, wherein the lipid ingredient comprises DSPC, DPSG and cholesterol in a molar ratio of about 3:1:2, and said liposomes having compressibility less than 0.7 mL/g.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 93.0
- Lexical Diversity: 1.73333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13804707', '13130525', '11921022', '14352662', '15891170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.715793124244811
- 35 USC 102 Novelty (BERT): 0.6029733954285483
- Combined Prediction Score: 0.7045111513631848
- Mean Citation Score: 352.36861800000014
- Max Citation Score: 568.1460599999998
- Similarity Product: 448.6087130105743

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test